X |
Filing Date |
Trade Date |
Ticker |
Company | Industry | Ins |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 | 2019-10-08 | SOR | Source Capital Inc /de/ | Closed-End Funds | 2 | P - Purchase | $35.94 | +8,617 | 8,617 | % | +$309,666 | |||||
| 5 M | 2019-10-10 | TLRD | Tailored Brands Inc | Apparel & Accessory Stores | 3 | P - Purchase | $4.36 | +57,369 | 198,449 | +41% | +$250,238 | |||||
| 5 M | 2019-10-08 | CWH | Camping World Holdings, Inc. | Auto Dealers & Gasoline Stations | 3 | P - Purchase | $7.86 | +1,038,474 | 6,261,512 | +20% | +$8,161,852 | |||||
| 11 D | 2019-10-07 | APRE | Aprea Therapeutics, Inc. | Pharmaceutical Preparations | 11 | P - Purchase | $15.00 | +1,948,233 | 13,054,471 | +18% | +$29,223,495 | |||||
| 5 M | 2019-08-26 | WOW | Wideopenwest, Inc. | Cable & Other Pay Television Services | 4 | P - Purchase | $5.59 | +563,147 | 32,690,229 | +2% | +$3,150,635 | |||||
| 13 M | 2019-10-08 | KDP | Keurig Dr Pepper Inc. | Beverages | 4 | P - Purchase | $27.54 | +84,554 | 376,980 | +29% | +$2,328,832 | |||||
| 3 M | 2019-10-07 | CNNE | Cannae Holdings, Inc. | Eating & Drinking Places | 2 | P - Purchase | $28.05 | +33,699 | 332,041 | +11% | +$945,205 | |||||
| 7 M | 2019-10-03 | WMS | Advanced Drainage Systems, Inc. | Plastics Foam Products | 3 | P - Purchase | $30.03 | +4,720,766 | 25,770,111 | +22% | +$141,766,954 | |||||
| 3 | 2019-10-04 | HRTX | Heron Therapeutics, Inc. /de/ | Pharmaceutical Preparations | 3 | P - Purchase | $17.50 | +295,428 | 5,933,893 | +5% | +$5,169,991 | |||||
| 2 DM | 2019-10-03 | BCDA | Biocardia, Inc. | Biological Products, (No Diagnostic Substances) | 2 | P - Purchase | $5.92 | +172,366 | 1,162,094 | +17% | +$1,019,767 |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2019-10-04 | AGO | Assured Guaranty Ltd | Feldstein Andrew T | Chief Investment Officer | P - Purchase | $43.89 | +23,600 | 47,600 | +98% | +$1,035,692 | |||||
| M | 2019-10-08 | AGO | Assured Guaranty Ltd | Feldstein Andrew T | Chief Investment Officer | P - Purchase | $44.45 | +23,200 | 70,800 | +49% | +$1,031,124 | |||||
2019-10-07 | MOSC | Mosaic Acquisition Corp. | Maura David M | Pres, CEO, 10% | P - Purchase | $10.30 | +24,812 | 219,996 | +13% | +$255,564 | ||||||
2019-10-08 | SOR | Source Capital Inc /de/ | Romick Steven T | VP, Portfolio Manager | P - Purchase | $35.92 | +6,535 | 8,200 | +392% | +$234,721 | ||||||
2019-10-08 | KDP | Keurig Dr Pepper Inc. | Denooyer Mary Beth | CHRO | P - Purchase | $27.10 | +6,000 | 54,000 | +13% | +$162,578 | ||||||
2019-10-08 | OVID | Ovid Therapeutics Inc. | Levin Jeremy M | CEO, 10% | P - Purchase | $2.50 | +60,000 | 5,237,106 | +1% | +$150,000 | ||||||
2019-10-07 | HCAP | Harvest Capital Credit Corp | Jolson Joseph A | CEO, 10% | P - Purchase | $9.80 | +6,808 | 792,907 | +1% | +$66,718 | ||||||
2019-10-07 | SOR | Source Capital Inc /de/ | Romick Steven T | VP, Portfolio Manager | P - Purchase | $35.98 | +1,665 | 1,665 | New | +$59,900 | ||||||
2019-10-10 | SNDX | Syndax Pharmaceuticals Inc | Morrison Briggs | CEO | P - Purchase | $5.40 | +11,000 | 31,400 | +54% | +$59,400 | ||||||
2019-10-10 | TLRD | Tailored Brands Inc | Rhodes A Alexander | EVP, GC | P - Purchase | $3.87 | +13,369 | 73,428 | +22% | +$51,738 |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019-10-09 | AMAR | Amarillo Biosciences Inc | Chen Stephen T | Pres,COB,CEO,CFO, 10% | P - Purchase | $0.38 | +2,000 | 7,113,556 | 0% | +$760 | ||||||
| M | 2019-10-09 | NGM | Ngm Biopharmaceuticals Inc | Goeddel David V | 10% | P - Purchase | $10.44 | +53,172 | 16,410,079 | 0% | +$555,293 | |||||
| M | 2019-10-09 | NGM | Ngm Biopharmaceuticals Inc | Svennilson Peter | 10% | P - Purchase | $10.44 | +53,172 | 16,240,079 | 0% | +$555,293 | |||||
2019-10-11 | ARTL | Artelo Biosciences, Inc. | Gorgas Gregory D. | Pres, CEO, CFO, Treas, Secr | P - Purchase | $1.96 | +2,700 | 241,209 | +1% | +$5,296 | ||||||
| M | 2019-10-09 | NGM | Ngm Biopharmaceuticals Inc | Column Group L P | 10% | P - Purchase | $10.44 | +53,172 | 16,235,079 | 0% | +$555,293 | |||||
| M | 2019-10-09 | NGM | Ngm Biopharmaceuticals Inc | Column Group L P | 10% | P - Purchase | $10.44 | +53,172 | 16,235,079 | 0% | +$555,293 | |||||
2019-10-09 | STLY | Hg Holdings, Inc. | Solas Capital Management, LLC | 10% | P - Purchase | $0.55 | +1,051 | 2,986,235 | 0% | +$578 | ||||||
| M | 2019-10-09 | SLGG | Super League Gaming, Inc. | Jung Mark | Dir | P - Purchase | $4.00 | +6,608 | 39,812 | +20% | +$26,430 | |||||
2019-10-10 | CDLX | Cardlytics, Inc. | Sosin Clifford | 10% | P - Purchase | $34.67 | +14,842 | 2,618,813 | +1% | +$514,572 | ||||||
| M | 2019-09-25 | ZIVO | Zivo Bioscience, Inc. | Maggiore Christopher D. | Dir, 10% | P - Purchase | $0.09 | +82,500 | 22,234,520 | 0% | +$7,425 |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2019-10-09 | ATH | Athene Holding Ltd | Gillis Frank Lauren | See Remarks | S - Sale+OE | $37.81 | -19,500 | 167,817 | -10% | -$737,371 | |||||
| D | 2019-10-10 | ARWR | Arrowhead Pharmaceuticals, Inc. | Anzalone Christopher Richard | CEO | S - Sale+OE | $31.83 | -56,325 | 2,121,903 | -3% | -$1,792,825 | |||||
| D | 2019-10-10 | CSOD | Cornerstone Ondemand Inc | Salen Kristina | Dir | S - Sale+OE | $54.78 | -9,740 | 13,990 | -41% | -$533,547 | |||||
| M | 2019-10-10 | MXL | Maxlinear Inc | Seendripu Kishore | COB, Pres, CEO, 10% | S - Sale | $22.14 | -20,800 | 1,331,999 | -2% | -$460,522 | |||||
2019-10-11 | ALK | Alaska Air Group, Inc. | Pedersen Brandon | EVP, FINANCE, CFO | S - Sale | $67.01 | -4,024 | 22,500 | -15% | -$269,631 | ||||||
| D | 2019-10-11 | OMCL | Omnicell, Inc | Seidelmann Scott Peter | EVP, Chief Commercial Officer | S - Sale+OE | $75.26 | -1,534 | 52,666 | -3% | -$115,454 | |||||
2019-10-09 | ENPH | Enphase Energy, Inc. | Kothandaraman Badrinarayanan | Pres, CEO | S - Sale | $23.72 | -10,000 | 512,490 | -2% | -$237,230 | ||||||
2019-10-09 | ENPH | Enphase Energy, Inc. | Branderiz Eric | VP, CFO | S - Sale | $23.72 | -10,000 | 380,560 | -3% | -$237,183 | ||||||
2019-10-09 | ENPH | Enphase Energy, Inc. | McNeil Jeff | COO | S - Sale | $24.03 | -7,500 | 310,538 | -2% | -$180,234 | ||||||
| M | 2019-10-09 | CRVL | Corvel Corp | Clemons V Gordon | COB | S - Sale | $77.42 | -6,000 | 1,765,146 | 0% | -$464,512 |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2019-10-09 | NGM | Ngm Biopharmaceuticals Inc | Goeddel David V | 10% | P - Purchase | $10.44 | +53,172 | 16,410,079 | 0% | +$555,293 | |||||
| M | 2019-10-09 | NGM | Ngm Biopharmaceuticals Inc | Svennilson Peter | 10% | P - Purchase | $10.44 | +53,172 | 16,240,079 | 0% | +$555,293 | |||||
2019-10-11 | ARTL | Artelo Biosciences, Inc. | Gorgas Gregory D. | Pres, CEO, CFO, Treas, Secr | P - Purchase | $1.96 | +2,700 | 241,209 | +1% | +$5,296 | ||||||
2019-10-10 | EXEL | Exelixis, Inc. | Haley Patrick J. | SVP, Commercial | S - Sale | $16.27 | -303 | 123,396 | 0% | -$4,930 | ||||||
| M | 2019-10-09 | NGM | Ngm Biopharmaceuticals Inc | Column Group L P | 10% | P - Purchase | $10.44 | +53,172 | 16,235,079 | 0% | +$555,293 | |||||
| M | 2019-10-09 | NGM | Ngm Biopharmaceuticals Inc | Column Group L P | 10% | P - Purchase | $10.44 | +53,172 | 16,235,079 | 0% | +$555,293 | |||||
| D | 2019-10-09 | ATH | Athene Holding Ltd | Gillis Frank Lauren | See Remarks | M - OptEx | $10.00 | +9,500 | 167,817 | +6% | +$95,000 | |||||
| D | 2019-10-09 | ATH | Athene Holding Ltd | Gillis Frank Lauren | See Remarks | S - Sale+OE | $37.81 | -19,500 | 167,817 | -10% | -$737,371 | |||||
| D | 2019-10-10 | ARWR | Arrowhead Pharmaceuticals, Inc. | Anzalone Christopher Richard | CEO | M - OptEx | $5.20 | +56,325 | 2,121,903 | +3% | +$292,890 | |||||
| D | 2019-10-10 | ARWR | Arrowhead Pharmaceuticals, Inc. | Anzalone Christopher Richard | CEO | S - Sale+OE | $31.83 | -56,325 | 2,121,903 | -3% | -$1,792,825 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |